mounjaro a glp 1 Diabetes Patients Also Struggle to Access GLP-1 Agonists Mounjaro dominates GLP-1 segment that
Description
Cell Reports, 31, 107768
Hormone replacement therapy (HRT) and contraception are commonly prescribed in primary care, and both are potentially affected by GLP-1 agonists
The review found that semaglutide and tirzepatide showed the highest reported rates of hair loss signals among GLP-1 therapies , with telogen effluvium and androgenetic alopecia being the most commonly reported hair-loss patterns
This sounds excessive, but the impact on absorption is real
Halloum, W., Dughem, Y
